Well, here's a list of the various benefits BPC-157 can have on your body
Obesity, insulin resistance, diabetes and cardiovascular risk in children: an American Heart Association scientific statement from the Atherosclerosis, Hypertension and Obesity in the Young Committee (Council on Cardiovascular Disease in the Young) and the Diabetes Committee (Council on Nutrition, Physical Activity and Metabolism)
Seiji Yano (Cancer Research Institute of Kanazawa University) and Prof
Pancreatic Cancer There is no evidence that Ozempic or other GLP-1 drugs increase the risk of pancreatic cancer
Jaclyn Leong, Medical Director of the UCI Health Weight Management Program, at the ObesityHelp 2025 National Conference, where she discussed evidence-based nutrition, resistance training, and integrative strategies to support lean body mass during GLP-1 therapy